ATE264125T1 - Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung - Google Patents
Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellungInfo
- Publication number
- ATE264125T1 ATE264125T1 AT00951845T AT00951845T ATE264125T1 AT E264125 T1 ATE264125 T1 AT E264125T1 AT 00951845 T AT00951845 T AT 00951845T AT 00951845 T AT00951845 T AT 00951845T AT E264125 T1 ATE264125 T1 AT E264125T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- topical use
- menthol
- production
- composition containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000465A IT1306171B1 (it) | 1999-07-21 | 1999-07-21 | Composizione farmaceutica a base di c2 hcl3o2, un polimero h (och2ch2)6oh, acido 2-idrossibenzoico, (1alfa, 2beta, 5alfa) -5-metil-2- |
PCT/IT2000/000309 WO2001005387A2 (en) | 1999-07-21 | 2000-07-21 | Pharmaceutical composition containing trichloroacetic acid, 2-oh benzoic and menthol for topical application, uses and process for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE264125T1 true ATE264125T1 (de) | 2004-04-15 |
Family
ID=11406895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00951845T ATE264125T1 (de) | 1999-07-21 | 2000-07-21 | Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1218063B8 (de) |
AT (1) | ATE264125T1 (de) |
AU (1) | AU6468800A (de) |
CA (1) | CA2379653A1 (de) |
DE (1) | DE60009933D1 (de) |
IT (1) | IT1306171B1 (de) |
WO (1) | WO2001005387A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7128903B2 (en) | 2001-10-03 | 2006-10-31 | Innovative Pharmaceutical Concepts (Ipc) Inc. | Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same |
US20090269390A1 (en) * | 2008-04-25 | 2009-10-29 | Medtronic, Inc. | Medical devices, polymers, compositions, and methods for delivering a haloacetate |
ES2758349T3 (es) * | 2010-07-15 | 2020-05-05 | Progressare Medinvest B V | Composición para el tratamiento de lesiones de la piel y/o de las uñas |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0059441A1 (de) * | 1981-03-02 | 1982-09-08 | Füssener Textil AG | Bioaktives Mittel auf Terpen/alpha-Ketocarbonsäure-Basis |
IT1190349B (it) * | 1986-06-16 | 1988-02-16 | Prodotti Formenti Srl | Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle |
DE3622089A1 (de) * | 1986-07-02 | 1988-01-07 | Krueger Gmbh & Co Kg | Viruzides mittel mit breitbandwirkung |
-
1999
- 1999-07-21 IT IT1999RM000465A patent/IT1306171B1/it active
-
2000
- 2000-07-21 AU AU64688/00A patent/AU6468800A/en not_active Abandoned
- 2000-07-21 AT AT00951845T patent/ATE264125T1/de not_active IP Right Cessation
- 2000-07-21 DE DE60009933T patent/DE60009933D1/de not_active Expired - Lifetime
- 2000-07-21 WO PCT/IT2000/000309 patent/WO2001005387A2/en active IP Right Grant
- 2000-07-21 EP EP00951845A patent/EP1218063B8/de not_active Expired - Lifetime
- 2000-07-21 CA CA002379653A patent/CA2379653A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IT1306171B1 (it) | 2001-05-30 |
DE60009933D1 (de) | 2004-05-19 |
ITRM990465A1 (it) | 2001-01-21 |
WO2001005387A3 (en) | 2001-09-13 |
CA2379653A1 (en) | 2001-01-25 |
WO2001005387A2 (en) | 2001-01-25 |
EP1218063A2 (de) | 2002-07-03 |
EP1218063B8 (de) | 2004-09-22 |
EP1218063B1 (de) | 2004-04-14 |
ITRM990465A0 (it) | 1999-07-21 |
AU6468800A (en) | 2001-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bruschi et al. | Oral bioadhesive drug delivery systems | |
EE03137B1 (et) | Veterinaarravim ja protsess selle valmistamiseks | |
EP1428821A8 (de) | Piperidin-4-ylamine mit analgetischer Wirksamkeit | |
ATE258426T1 (de) | Zusammensetzungen und verfahren zur topischen anwendungen von wirkstoffen | |
CY1105707T1 (el) | Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου | |
DE60212475D1 (de) | Pharmazeutische Tablette und eine Verfahren zu deren Herstellung | |
ATE326264T1 (de) | Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung | |
BR0210489A (pt) | Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente | |
KR20150063567A (ko) | 고형 제형 | |
CA2468906A1 (en) | Use of selenite-containing compounds to be topically or buccally administered | |
ATE264125T1 (de) | Pharmazeutische zusammensetzung enthaltend trichloroessigsäure, 2-oh benzoesäure und menthol zur topischen anwendung und verfahren zu deren herstellung | |
IS1771B (is) | Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif | |
DE60104442D1 (de) | Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen | |
BR9605890A (pt) | Peptido fisiologicamente ativo purificado peptídeo em forma dimérica sais de adição de ácido de peptídeo sais de base de peptídeos formas de dosagem oral intra-traqueal e nasal formulação farmacêutica processos para a preparação da mesma para induzir uma resposta imunomodulatória em um mamifero e para fabricar um peptídeo | |
MY130445A (en) | Novel formulations of alpha-2, 4-disulfophenyl-n-tert-butylnitrone | |
ES2139774T3 (es) | Uso de una combinacion de antineoplastones en la preparacion de un medicamento para el tratamiento de la neurofibromatosis. | |
AR011707A1 (es) | Composicion farmaceutica que comprende tirosina y un alergeno opcionalmente modificado, procedimiento para su preparacion y el uso de la misma para la manufactura de un medicamento. | |
ATE282407T1 (de) | Arzneimittel-überzugszubereitung und verfahren zu ihrer anwendung | |
ATE212840T1 (de) | Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung | |
DE60202299D1 (de) | Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten | |
CN1432410A (zh) | 一种皮肤快速止痛外用制剂 | |
ATE484516T1 (de) | 3.beta.,28-diacetoxy-18-oxo-19,20,21,29,30- pentanorlupan-22-säure solvate, verfahren zu ihrer herstellung und pharmazeutische präparate daraus | |
HUP0002905A2 (hu) | 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása | |
EP0666078A2 (de) | Nasensprayzusammensetzungen | |
CA2161683A1 (en) | Veterinary composition containing a proton pump inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |